At 18 months median follow up of a phase 1 clinical trial, one patient’s cancer had worsened, two had died, and nine remained free of disease. Testing of blood and tumor samples showed that CUDC-101 had indeed inhibited the action of EGFR, HDAC and Her2.
from Top Health News — ScienceDaily http://bit.ly/1z33vXG via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1JQRg3j
No comments:
Post a Comment